Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area

Eur J Dermatol. 2019 Feb 1;29(1):82-83. doi: 10.1684/ejd.2018.3440.

Authors

Sophie Leducq¹, Sandy Vrignaud², Gérard Lorette¹, Denis Herbreteau¹, Vincent Dubee³, Ludovic Martin⁴, Annabel Maruani¹

Affiliations

¹ University Hospital of Tours, Department of Dermatology, Unit of Pediatric Dermatology, Center of Reference of Cutaneous Vascular Malformations (MAGEC), Tours, France.
² University Hospital of Angers, Department of Pharmacy, Angers, France.
³ University Hospital of Angers, Department of Infectious and Tropical Diseases, Angers, France.
⁴ University Hospital of Angers, Department of Dermatology, Angers, France.

PMID: 30530427
DOI: 10.1684/ejd.2018.3440

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Topical
Adolescent
Buttocks
Humans
Immunosuppressive Agents / therapeutic use*
Lymphatic Abnormalities / drug therapy*
Male
Sirolimus / therapeutic use*

Substances

Immunosuppressive Agents
Sirolimus